Level of Evidence: 5. Technical Efficacy Stage: 3. J. Magn. Reson. Imaging 2018;47:1169–1171.
- hepatobiliary contrast agent
- hepatocellular carcinoma
- magnetic resonance imaging
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging
for the LI-RADS HBA Working Group (2018). Recommendation for terminology: Nodules without arterial phase hyperenhancement and with hepatobiliary phase hypointensity in chronic liver disease. Journal of Magnetic Resonance Imaging, 48(5), 1169-1171. https://doi.org/10.1002/jmri.26515